홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
IMCR
#2129
Immunocore Holdings plc American Depositary Shares
31.690
0
USD
+0.70%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+0.70%
월간 변동
+4.38%
6달 변화
-5.35%
년간 변동율
-5.35%
이전 종가
31.470
0
Open
31.690
0
Bid
Ask
Low
31.690
0
High
31.690
0
양
87
마켓
주식
헬스케어
IMCR
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2020
2021
2022
2023
2024
2025
Total assets
—
—
—
597 M
1.01 B
1.07 B
Total liabilities
—
—
—
228.16 M
648.79 M
686.24 M
Total equity
—
—
—
368.84 M
360.72 M
381.03 M
Total liabilities & shareholders' equities
—
—
—
597 M
1.01 B
1.07 B
Total debt
—
—
—
48.01 M
391.01 M
393.13 M
Net debt
—
—
—
-306.61 M
-387.65 M
-427.47 M
Immunocore Holdings plc - American Depositary Shares
Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.
뉴스
Ideaya Biosciences Surges On Promising Results For Hard-To-Treat Melanoma
제퍼리스, 이뮤노코어 투자의견 하향…매출 우려
Jefferies downgrades Immunocore stock rating on revenue concerns
Immunocore, 전략적 성장 및 혁신 발표
Immunocore at Leerink Conference: Strategic Growth and Innovation
Immunocore Holdings plc 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:IMCR) 2026-02-25
Immunocore Holdings plc (IMCR) Q4 2025 Earnings Call Transcript
이뮤노코어 홀딩스 Q4 실적, 수익 에상치보다 저조
Immunocore Holdings earnings missed by $0.40, revenue fell short of estimates
JAZZ Stock Rises as Q4 Earnings & Sales Top Expectations
RXRX Q4 Loss Narrower Than Expected, Revenues Increase Y/Y, Stock Up
Repligen's Q4 Earnings Beat Estimates, Revenues Surge Y/Y